Eugene Pietzak

Areas of Expertise

Conditions I Treat

Bladder cancer
Prostate cancer and conditions
Urothelial carcinoma (transitional cell carcinoma)

My Specialties

Robotic surgery
Urinary reconstruction
Open surgery

Request an Appointment

Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified urologic surgeon who specializes in the surgical treatment of bladder cancer, prostate cancer, upper urothelial cancer (cancers that arise in the renal pelvis and ureters), and other cancers of the genitourinary system. I have expertise in a wide array of surgical techniques, including minimally invasive and robotic surgery.

I see patients at the Sidney Kimmel Center for Prostate and Urologic Cancers in Manhattan and MSK Commack on Long Island.

This provider is part of a team that was ranked #1 in the nation for Urology Cancer Care this year by U.S. News & World Report.

I am committed to achieving cures while preserving quality of life through careful surgical planning and meticulous surgical technique. Whenever possible, I use nerve-sparing and function-sparing techniques to help maintain urinary and sexual function. For men with prostate cancer that requires treatment, I primarily perform robotic-assisted radical prostatectomy. For men and women with bladder cancer who require an operation to remove the bladder (radical cystectomy), I can provide expertise in advanced urinary reconstructive techniques, such as continent neobladder diversion that can re-create the natural urination pathway after bladder removal.

Because the treatment of cancers of the genitourinary system is complex, I work closely with colleagues in medical oncology, radiation oncology, radiology, and pathology to individualize each patient’s treatment approach based on their unique circumstance. I understand that a cancer diagnosis requires people to make many important and oftentimes, difficult decisions. I work with each of my patients and their families to provide as much information as possible regarding all options available to them. By using a patient-centered approach that takes into account individual preferences, I can provide the best possible outcome and quality of life following treatment for all my patients.

In addition to my surgical expertise, I am a surgeon-scientist involved in clinical trials and translational research working towards the development of new treatments for people with bladder cancer, prostate cancer, and upper tract urothelial cancer. We have a large research program focused on identifying ways to personalize and improve treatment options for people with bladder cancer. Our research has led to the development of several clinical trials available at MSK of new treatment approaches for people with bladder cancer so those participating in these trials may receive cutting-edge therapies before they are accessible nationally. The ultimate goal of our research efforts is to provide a better chance of cure and improved quality of life for our patients compared to currently available standard therapies.

What I Do at MSK

I'm a urologic surgeon, which is a doctor with special training in surgery on the genitourinary (jeh-nih-toh-YOOR-ih-nayr-ee) (GU) system. This includes the bladder, kidney, penis, prostate, and testicles.

Assistant Attending Surgeon

Conditions I Treat

Bladder cancer
Prostate cancer and conditions
Urothelial carcinoma (transitional cell carcinoma)

My Specialties

Robotic surgery
Urinary reconstruction
Open surgery
Nerve-sparing surgery

Education

MD, Stony Brook University Medical School

Residencies

Urology - Hospital of the University of Pennsylvania

Fellowships

Urologic Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Urology

Awards and Honors

Castle Connolly: America’s Top Doctor (2025)
Castle Connolly: America’s Top Doctor (2024)
Top Doctors New York Metro Area, Castle Connolly (2023)
Castle Connolly: America's Top Doctors (2023)
Alpha Omega Alpha
National Cancer Institute’s K12 Paul Calabresi Career Development Award for Clinical Oncology
Society of Urologic Oncology/ American Urologic Association Research Scholar Award
MSKCC Specialized Program of Research Excellence (SPORE) Career Enhancement Award in Bladder Cancer
Bladder Cancer Advocacy Network (BCAN) Young Investigator Award

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

New Patients

Scheduling an appointment is easy. Click or call 646-497-9068— we’re available 24 hours a day, 7 days a week

Make an Appointment

Current Patients

Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone

646-422-4781

Location

New York, NY

Commack, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Urology Service doctors

Clinical Trials

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.

Male Neobladder.

Neoadjuvant Treatment of High-Risk, Clinically Localized Prostate Cancer Prior to Radical Prostatectomy.

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH. Eur Urol. 2017 Jun 2.

Publications on PubMed

Visit PubMed for a full listing of Dr. Pietzak’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Eugene Pietzak discloses the following relationships and financial interests:

CG Oncology, Inc.
Professional Services and Activities
Janssen Global Services, LLC
Professional Services and Activities
Merck & Co Inc.
Professional Services and Activities

QED Therapeutics, Inc.
Professional Services and Activities
UroGen Pharma, Inc.
Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.

View all disclosures